Jacobs Levy Equity Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-596,108
| Closed | -$3.74M | – | 1136 |
|
|
2025
Q1 | $3.74M | Buy |
+596,108
| New | +$3.74M | 0.01% | 517 |
|
|
2024
Q2 | – | Sell |
-20,987
| Closed | -$223K | – | 1024 |
|
|
2024
Q1 | $223K | Sell |
20,987
-572,764
| -96% | -$6.08M | ﹤0.01% | 883 |
|
|
2023
Q4 | $5.42M | Buy |
593,751
+312,819
| +111% | +$2.86M | 0.03% | 410 |
|
|
2023
Q3 | $2.91M | Buy |
280,932
+210,129
| +297% | +$2.18M | 0.02% | 492 |
|
|
2023
Q2 | $1.01M | Buy |
+70,803
| New | +$1.01M | 0.01% | 695 |
|
|
2022
Q1 | – | Sell |
-165,642
| Closed | -$3.26M | – | 1064 |
|
|
2021
Q4 | $3.26M | Buy |
165,642
+94,608
| +133% | +$1.86M | 0.02% | 514 |
|
|
2021
Q3 | $2.28M | Sell |
71,034
-44,305
| -38% | -$1.42M | 0.02% | 588 |
|
|
2021
Q2 | $3.9M | Buy |
+115,339
| New | +$3.9M | 0.03% | 485 |
|